Sara van den Berg

233 A List of publications LIST OF PUBLICATIONS S.P.H. van den Berg ., A. Wong, M. Hendriks, R. H. J. Jacobi, D. van Baarle and J. van Beek (2018). Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults. Front Immunol. S.P.H. van den Berg , K. Warmink, J. A. M. Borghans, M. J. Knol and D. van Baarle (2019). Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis. Med Microbiol Immunol. S.P.H. van den Berg , I. N. Pardieck, J. Lanfermeijer, D. Sauce, P. Klenerman, D. van Baarle and R. Arens (2019). The hallmarks of CMV-specific CD8 T-cell differentiation. Med Microbiol Immunol. L.D. Samson*, S.P.H. van den Berg *, P. Engelfriet, A. M. H. Boots, M. Hendriks, L.G.H. de Rond , M. de Zeeuw-Brouwer, M.Verschuren, J. A.M. Borghans, A. Buisman # , and D. van Baarle # (2020). Limited effect of duration of CMV infection on adaptive immunity and frailty: insights from a 27-year long longitudinal study. Accepted for publication. Clin Trans Immunol * first authors contributed equally # last authors contributed equally. S.P.H. van den Berg , L.Y. Derksen, J. Drylewicz, N. M. Nanlohy, L. Beckers, J. Lanfermeijer, S. N. Gessel, M. Vos, S. Otto, R. de Boer, K. Tesselaar, J.A.M.Borghans* and D. van Baarle*. Quantification of T-cell dynamics during latent human cytomegalovirus infection. Submitted for publication. S.P.H. van den Berg , J. Lanfermeijer, R.H.J Jacobi, M. Hendriks, M. Vos, R. van Schuijlenburg, N.M. Nanlohy, J.A.M. Borghans, J. van Beek, D. van Baarle and J. de Wit. Lower influenza virus-specific memory T-cell frequencies, but no impaired T-cell response to acute influenza virus infection by latent CMV infection. Submitted for publication. Jackson, S.E., A. Redeker, R. Arens, D. van Baarle, S.P.H. van den Berg , C.A. Benedict, L. Cicin-Sain, A.B. Hill and M.R. Wills (2017). CMV immune evasion and manipulation of the immune system with aging. Geroscience. Shan, L., S. Li, J. Meeldijk, B. Blijenberg, A. Hendriks, K. van Boxtel, S.P.H. van den Berg , I. J. Groves, M. Potts, A. Svrlanska, T. Stamminger, M.R. Wills and N. Bovenschen (2020). Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic manner. PLoS Pathog.